# Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection

> **NCT02095951** · PHASE4 · COMPLETED · sponsor: **Children's Hospital of Michigan** · enrollment: 30 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Blood Disorders
- Solid Tumors

## Interventions

- **DRUG:** Ethanol lock therapy (ELT)

## Key facts

- **NCT ID:** NCT02095951
- **Lead sponsor:** Children's Hospital of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02095951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02095951, "Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02095951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*